Gritstone bio, Inc. Common Stock (GRTS)

GRTS was delisted on the 21st of October, 2024.

• Market cap: $3.8M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Employees: 231